Coeptis Therapeutics, Inc.

COEP · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$4,908$1,997$4,268$533
Short-Term Investments$422$991$0$0
Receivables$86$30$0$0
Inventory$0$0$0$0
Other Curr. Assets$0$0$0$0
Total Curr. Assets$5,991$3,695$4,651$1,051
Property Plant & Equip (Net)$39$50$60$60
Goodwill$0$0$0$0
Intangibles$1,211$452$497$542
Long-Term Investments$9,041$6,941$6,941$5,691
Tax Assets$0$0$0$0
Other NC Assets$0$1,054$1,304$1,565
Total NC Assets$10,291$8,497$8,802$7,857
Other Assets$0$0$0$0
Total Assets$16,282$12,191$13,453$8,909
Liabilities
Payables$783$1,029$1,121$1,270
Short-Term Debt$130$1,142$1,839$1,188
Tax Payable$0$0$0$0
Deferred Revenue$0$1,631$1,187$0
Other Curr. Liab.$1,792$235$870$1,276
Total Curr. Liab.$2,705$4,475$5,652$4,513
LT Debt$150$150$150$150
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$410$467$169$359
Total NC Liab.$560$636$338$528
Other Liabilities$0$0$0$0
Cap. Leases$0$41$51$61
Total Liabilities$3,265$5,111$5,990$5,041
Equity
Pref Stock$0$0$0$0
Common Stock$1$0$0$0
Retained Earnings-$108,376-$105,989-$101,655-$98,234
AOCI$0$0$0$0
Other Equity$0$234-$250-$1,558
Total Equity$12,466$6,096$6,479$3,185
Supplemental Information
Minority Interest$551$984$984$682
Total Liab. & Tot. Equity$16,282$12,191$13,453$8,909
Net Debt-$4,629-$705-$2,279$805
Coeptis Therapeutics, Inc. (COEP) Financial Statements & Key Stats | AlphaPilot